Bot MD
By Bot M.D.
Bot MD is a clinical AI assistant for physicians that provides instant access to hospital-specific protocols and documentation tools on iOS.
The App DNA
What makes this app unique?
The platform removes the time cost of searching through fragmented internal hospital directories and paper-based protocols by centralizing institutional data into a single queryable interface.
For Physicians and healthcare professionals requiring rapid access to hospital-specific clinical information.
What does it look like?
Key features
Provides instant access to hospital-specific content including call rosters, directory information, and drug formularies.
Converts dictated clinical notes into text format to reduce administrative burden.
Answers clinical questions based on uploaded hospital protocols and guidelines.
How much does it cost?
The platform is listed as free, but lacks public pricing or subscription tiers, suggesting a B2B-only revenue model.
Velocity
Dormant developmentplatform expansionShow more...
Bot MD has been inactive for 548 days, placing it firmly in the zombie category. The only available version in the analyzed window provided limited access for a specific hospital, but no subsequent updates or maintenance patches have been deployed since. Development appears to have ceased entirely given the lack of activity over the past year and a half.
Who built it?
User Sentiment
What do users think recently?
How are ratings & reviews evolving?
Not enough recent reviews to extract reliable themes yet.
Read the full review analysisCompetition
Competitive landscape for Bot MD
How's the Medical market?
Bot MD occupies a niche in the Medical category by focusing on institutional-specific data rather than general clinical knowledge. The lack of public pricing and the focus on hospital-specific content suggests a B2B-led strategy that bypasses traditional consumer-facing chart competition.
Read the market outlookThe rivals identified
Unlock the deeper market read.
Access the full report for freeThe Analyst's Read
Key takeaways for Bot MD
Where is it heading?
The clinical AI market is consolidating around tools that offer broader integration with electronic health records, which may pressure Bot MD's hospital-specific protocol model. If the platform does not resume a regular update cadence, it risks being displaced by more flexible, enterprise-wide AI solutions.
- The 18-month release gap suggests a transition to a maintenance-only posture, which limits the platform's ability to respond to new clinical AI standards.
The SWOT
- Institutional data digitization creates a defensible B2B distribution barrier
- Scaling NCCS trial framework into additional hospital networks
Next best moves
Audit institutional partnership pipeline because the 18-month release gap suggests stalled growth → stabilize B2B revenue
The counter-intuitive read
The 18-month release gap is not necessarily a failure…
Read the full takeBottom line
The reliance on institutional data creates a strong B2B moat, but the 18-month release gap threatens the platform's relevance as clinical AI standards evolve. Maintaining the current institutional partnerships is the priority until development velocity resumes.
Unlock 1 critical friction, 1 market threat and the analyst’s take.
Access the full report for freeSources
- [1] App Store
Report last updated